Short radiation course for early stage breast cancer
Part of Cancer, Injuries & trauma, Skin clinical trials.
This trial tests a shorter, more intense radiation schedule for women with early stage breast cancer after lumpectomy. It aims to provide effective treatment with fewer visits, which may be more convenient for patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a woman aged 45 to 74.
- Your life expectancy is longer than 5 years.
- You had breast-conserving surgery and will start radiation within 12 weeks (or within 8 weeks after finishing chemotherapy if you had it).
- Your cancer is a low or medium grade invasive ductal, mucinous, papillary, canalicular, or medullary carcinoma, or low-risk DCIS (tumor 2.5 cm or smaller, low to medium grade).
- Your tumor is 3 cm or smaller, has not spread to lymph nodes, and is hormone-receptor positive (ER and/or PR positive).
- You do not have certain other types of breast cancer (like invasive lobular carcinoma) or high-grade tumors, and you have not had chemotherapy or hormone therapy before surgery.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 2 trial tests a shorter, focused radiation treatment after breast surgery, either alone or with an extra targeted boost. It’s for people with low-risk breast cancer and no spread to distant organs, aiming to keep results while reducing treatment time and side effects.
This trial tests a single, targeted radiation treatment given during or after lumpectomy for early-stage breast cancer. It aims to make treatment more convenient while keeping the same safety and effectiveness as longer radiation courses.
This trial tests a short, more intense radiation schedule for women with certain breast cancer types or who are under 40. It aims to reduce treatment time while still targeting the whole breast and any high-risk areas.
This trial studies a radiation technique that treats only part of the breast using a faster schedule. It may help some people with early breast cancer after breast-conserving surgery by delivering effective treatment with less radiation to the rest of the breast.
This trial tests a shorter, more intense course of daily radiation therapy (called ultra hypo-fractionation) given after lumpectomy for early-stage breast cancer. The goal is to reduce the number of treatment visits while keeping the same high level of effectiveness and safety.
This trial tests whether a shorter, 3-day course of partial breast radiation after surgery works as well as standard radiation for women with early-stage breast cancer. It may help reduce time in treatment while aiming to keep cancer from coming back in the treated breast area.
Hear when a new Breast cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.